Actio Biosciences & KCNT1 Epilepsy Foundation: Bringing Meaningful Therapies from One to Many

Actio Biosciences meets with co-founder of the KCNT1 Epilepsy Foundation to discuss the science and motivation behind their KCNT1 epilepsy drug development program. This conversation highlights the urgent need for targeted treatments and the progress being made toward potential therapies for KCNT1-related epilepsy.

Key Topics Covered:

The challenges of KCNT1 epilepsy and the need for new treatments
How Actio Biosciences is working on a targeted KCNT1 therapy
The role of families, advocacy, and clinical trials in drug development
What this research means for the future of KCNT1 patients

Learn More:
Actio Biosciences: https://actiobiosciences.com
KCNT1 Epilepsy Foundation: https://kcnt1epilepsy.org

#KCNT1Epilepsy #KCNT1 #RareEpilepsy #ActioBiosciences #EpilepsyResearch